Jazz Pharmaceuticals: cannabis patents by patent family 2023

��ƽ��

Number of cannabis patents under Jazz Pharmaceuticals' subsidiaries as of May 2023, by patent family

Cannabis patents under Jazz Pharmaceuticals by patent family 2023

Last update:

Nov 1, 2023

Author:

��ƽ�� Research Department

Region:

Worldwide

Survey time period:

From 01/01/2023 to 31/12/2023

As of May 2023, Jazz Pharmaceuticals was heavily dominating the patent landscape for medical cannabis through its subsidiaries - GW Research Ltd. and GW Pharmaceuticals Ltd. The use of cannabinoids in the treatment of epilepsy was the first among leading patent families, with almost 100 active or pending patents. GW Pharmaceuticals was the largest cannabis-focused pharmaceutical company until 2021, when it was acquired by Jazz Pharmaceuticals.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Number of cannabis patents under Jazz Pharmaceuticals' subsidiaries as of May 2023, by patent family

Get in touch with us for additional information

��ƽ��